MicrobiologybioRxiv
The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication
I. L. Shytaj, M. Fares, B. Lucic…·M. Lusic
This study shows that cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication in cell lines and organoids, reducing viral replication to levels comparable to uninfected cells.
DOI 10.1128/mbio.03705-21